Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling

28 Sept 2015

Abstract excerpt

// Rebecca Lamb 1,2,* , Gloria Bonuccelli 1,2,* , Béla Ozsvári 1,2 , Maria Peiris-Pagès 1,2 , Marco Fiorillo 1,2,3 , Duncan L. Smith 4 , Generoso Bevilacqua 5,6 , Chiara Maria Mazzanti 5 , Liam A. McDonnell 5 , Antonio Giuseppe Naccarato 6 , Maybo Chiu 1,2 , Luke Wynne 1,2 , Ubaldo E. Martinez-Outschoorn 7 , Federica Sotgia 1,2 and Michael P. Lisanti 1,2 1 The Breast Cancer Now Research Unit,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26421711
DOI: 10.18632/oncotarget.5852

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signalingPMID 26421711Read ↗

High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistantSemantic proximity Read ↗

Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cellsSemantic proximity Read ↗

Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibitionSemantic proximity Read ↗

“Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial EnergySemantic proximity Read ↗

Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic SignificanceSemantic proximity Read ↗

Targeted Anti-Mitochondrial Therapy: The Future of OncologySemantic proximity Read ↗

Regulatory effect of Wnt signaling on mitochondria in cancer: from mechanism to therapySemantic proximity Read ↗

Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious diseaseSemantic proximity Read ↗

Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cellsSemantic proximity Read ↗

Hallmarks of cancer stem cell metabolismSemantic proximity Read ↗

Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs)Semantic proximity Read ↗

The Nutrigenomic Landscape of Mitochondrial Metabolism: Targeting Growth Factor Signaling in Translational OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.